Area of research
Health, Toxicology and Mutagenesis · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Effects and risks of endocrine disrupting chemicals, Toxic Organic Pollutants Impact, Thyroid Disorders and Treatments, and Birth, Development, and Health.
The Conflict between Regulatory Agencies over the 20,000-Fold Lowering of the Tolerable Daily Intake (TDI) for Bisphenol A (BPA) by the European Food Safety Authority (EFSA)
Letter to the editor regarding Hall et al. (2023): Fluoride exposure and hypothyroidism in a Canadian pregnancy cohort
A vision for safer food contact materials: Public health concerns as drivers for improved testing
Fluoride exposure and hypothyroidism in a Canadian pregnancy cohort
European Medicines Agency Conflicts With the European Food Safety Authority (EFSA) on Bisphenol A Regulation
Impacts of food contact chemicals on human health: a consensus statement
Data integration, analysis, and interpretation of eight academic CLARITY-BPA studies
Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification
The Use and Misuse of Historical Controls in Regulatory Toxicology: Lessons from the CLARITY-BPA Study
Polybrominated diphenyl ethers (PBDEs) and hydroxylated PBDE metabolites (OH-PBDEs) in maternal and fetal tissues, and associations with fetal cytochrome P450 gene expression
Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis
Project TENDR: Targeting Environmental Neuro-Developmental Risks The TENDR Consensus Statement
Scientific principles for the identification of endocrine-disrupting chemicals: a consensus statement
Peer-reviewed and unbiased research, rather than ‘sound science’, should be used to evaluate endocrine-disrupting chemicals
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
Executive Summary to EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
Estimating Burden and Disease Costs of Exposure to Endocrine-Disrupting Chemicals in the European Union
Neurobehavioral Deficits, Diseases, and Associated Costs of Exposure to Endocrine-Disrupting Chemicals in the European Union
Manufacturing doubt about endocrine disrupter science – A rebuttal of industry-sponsored critical comments on the UNEP/WHO report “State of the Science of Endocrine Disrupting Chemicals 2012”
The Impact of Endocrine Disruption: A Consensus Statement on the State of the Science
Temporal Comparison of PBDEs, OH-PBDEs, PCBs, and OH-PCBs in the Serum of Second Trimester Pregnant Women Recruited from San Francisco General Hospital, California
Science and policy on endocrine disrupters must not be mixed: a reply to a “common sense” intervention by toxicology journal editors
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
Endocrine-Disrupting Chemicals and Public Health Protection: A Statement of Principles from The Endocrine Society
Designing endocrine disruption out of the next generation of chemicals